1. Home
  2. PED vs ENTX Comparison

PED vs ENTX Comparison

Compare PED & ENTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pedevco Corp.

PED

Pedevco Corp.

SELL

Current Price

$13.47

Market Cap

179.0M

Sector

Energy

ML Signal

SELL

Logo Entera Bio Ltd.

ENTX

Entera Bio Ltd.

HOLD

Current Price

$2.50

Market Cap

147.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PED
ENTX
Founded
N/A
2010
Country
United States
Israel
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
179.0M
147.4M
IPO Year
2012
2015

Fundamental Metrics

Financial Performance
Metric
PED
ENTX
Price
$13.47
$2.50
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
★ $9.75
AVG Volume (30 Days)
33.9K
★ 523.4K
Earning Date
11-16-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ 0.22
Revenue
★ $45,751,000.00
$42,000.00
Revenue This Year
$212.12
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
$12.05
Revenue Growth
★ 15.67
N/A
52 Week Low
$8.64
$0.91
52 Week High
$133.98
$4.20

Technical Indicators

Market Signals
Indicator
PED
ENTX
Relative Strength Index (RSI) 48.87 37.60
Support Level $12.79 $1.46
Resistance Level $13.53 $3.08
Average True Range (ATR) 0.54 0.18
MACD -0.02 -0.03
Stochastic Oscillator 50.48 7.08

Price Performance

Historical Comparison
PED
ENTX

About PED Pedevco Corp.

PEDEVCO Corp is an oil and gas company focused on oil and natural gas development, exploration, and production. The company focuses on legacy properties with a long production history, well-defined geology, and existing infrastructure that can be leveraged when applying modern field management technologies. The current properties in the Denver-Julesberg Basin (D-J Basin) in Colorado and Wyoming, the Powder River Basin (PRB) in Wyoming, and the San Andres formation of the Permian Basin situated in West Texas and eastern New Mexico (the Permian Basin).

About ENTX Entera Bio Ltd.

Entera Bio Ltd is a clinical-stage biopharmaceutical company engaged in the development of orally delivered macromolecule therapeutics, including peptides and therapeutic proteins. The company focuses on underserved, chronic medical conditions where oral administration of a mini tablet peptide or peptide replacement therapy has the potential to perform. Its product candidates are: EB613, which is being developed as an oral, osteoanabolic (bone-building) tablet treatment for osteoporosis; EB612, being developed as an oral PTH(1-34) tablet peptide replacement therapy for patients with hypoparathyroidism; EB618, an Oral GLP-1 being developed to tackle obesity; and Oral GLP-2, a peptide tablet alternative for patients suffering from short bowel syndrome. The company operates in Israel.

Share on Social Networks: